BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Seagen Inc.
Genmab
Eli Lilly and Company
Pfizer
Coherus Oncology, Inc.
Pfizer
Revolution Medicines, Inc.
Merck Sharp & Dohme LLC
Tesaro, Inc.
Eli Lilly and Company
Jazz Pharmaceuticals
Toray Industries, Inc
AstraZeneca
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Cantargia AB
Cantargia AB
Nektar Therapeutics
Incyte Corporation
Eli Lilly and Company
Critical Outcome Technologies Inc.